Evidence map›Paper›PMID 28560516›Full record

SynthesisClinical research in cardiology : official journal of the German Cardiac Society2017

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Hai Deng, Ying Bai, Alena Shantsila, Laurent Fauchier, Tatjana S Potpara, Gregory Y H Lip

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Clinical research in cardiology : official journal of the German Cardiac Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Pooled it
  5. Trial
  6. Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Trial
  7. Article
  8. Predictive Value of the HELT-ECirculation reports · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Observational
  15. Management of atrial fibrillation in German military aircrew.Journal of occupational medicine and toxicology (London, England) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Extracellular Vesicles in Atrial Fibrillation-State of the Art.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

Hai DengInstitute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, B18 7QH, UK.
Ying BaiInstitute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, B18 7QH, UK.
Alena ShantsilaInstitute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, B18 7QH, UK.
Laurent FauchierService de Cardiologie, Centre Hospitalier Universitaire Trousseau, Tours, France.
Tatjana S PotparaSchool of Medicine, Belgrade University, Belgrade, Serbia.
Gregory Y H LipInstitute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, B18 7QH, UK. g.y.h.lip@bham.ac.uk.
Aalborg University · DKBeijing Tongren Hospital · CNBirmingham City Hospital · GBCentar za Promociju Nauke · RSCentre Hospitalier Universitaire de Tours · FRGuangdong General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with atrial fibrillation (AF) are commonly managed with rhythm control strategy, but the natural history of this common arrhythmia leads itself to progression from paroxysmal to persistent or permanent AF, and recurrences are evident despite rhythm control treatments using cardioversion or catheter ablation. Numerous clinical factors have been associated with outcomes of rhythm control or arrhythmia progression in patients with AF. The more common factors have been used to formulate risk stratification scores, to help predict the outcomes of rhythm control treatments or AF progression. This review article provides an overview on the published clinical risk scores related to outcomes of rhythm control strategy or AF progression.

Indexed as

Atrial FibrillationCardiac Resynchronization TherapyDisease ProgressionHeart RateHumansTreatment OutcomeAtrial fibrillationCardioversionCatheter ablationRhythm control

Identifiers

PMID28560516
PMCPMC5613037
OpenAlexW2619536148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.